Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30066179HIVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20010255HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20009841HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20008509HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20010233HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20061216HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20030399HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20044743HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS20023606HPVENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TVIS44013679HTLV-1ENSG00000197081.16protein_codingIGF2RNoNo3482P11717
TCGA Plot Options
Drug Information
GeneIGF2R
DrugBank IDDB13173
Drug NameCerliponase alfa
Target IDBE0003623
UniProt IDP11717
Regulation Typeligand
PubMed IDs22792360
CitationsMeng Y, Sohar I, Wang L, Sleat DE, Lobel P: Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification. PLoS One. 2012;7(7):e40509. doi: 10.1371/journal.pone.0040509. Epub 2012 Jul 6.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL3544921